BlackRock Discloses Significant Stake in Elanco Animal Health

Ticker: ELAN · Form: SC 13G · Filed: 2024-01-29T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, SC-13G, passive-investment

TL;DR

**BlackRock just confirmed a big stake in Elanco, signaling institutional confidence.**

AI Summary

BlackRock Inc. filed an SC 13G on January 29, 2024, disclosing its ownership of Elanco Animal Health Inc. common stock as of December 31, 2023. This filing indicates that BlackRock, a major institutional investor, holds a significant stake in Elanco, signaling its confidence in the animal health company. For investors, this matters because large institutional ownership can provide stability and a vote of confidence in the company's long-term prospects.

Why It Matters

This filing shows a major institutional investor, BlackRock, has a substantial position in Elanco, which can be seen as a positive signal for the company's stability and future outlook.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of institutional ownership and does not inherently present new risks, but rather confirms a significant investor's position.

Analyst Insight

An investor might view BlackRock's continued ownership as a positive sign, suggesting stability and potential long-term value in Elanco. It could prompt further research into Elanco's fundamentals and BlackRock's investment thesis.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this document?

This document is an SC 13G filing, specifically designated as an initial filing under Rule 13d-1(b) as indicated by the 'X' in the appropriate box.

Who is the reporting person in this SC 13G filing?

The reporting person is BlackRock, Inc., as stated under '(1) Names of reporting persons. BlackRock, Inc.' on the cover page.

What is the name of the issuer whose securities are being reported?

The issuer is Elanco Animal Health Incorporated, as clearly stated under '(Name of Issuer)' on the Schedule 13G form.

What is the CUSIP number for the securities mentioned in this filing?

The CUSIP number for the common stock of Elanco Animal Health Incorporated is 28414H103, as listed on the Schedule 13G form.

What was the 'Date of Event Which Requires Filing of this Statement'?

The date of the event which required the filing of this statement was December 31, 2023, as specified on the Schedule 13G form.

From the Filing

0001086364-24-005564.txt : 20240129 0001086364-24-005564.hdr.sgml : 20240129 20240129172549 ACCESSION NUMBER: 0001086364-24-005564 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90921 FILM NUMBER: 24574868 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc. CENTRAL INDEX KEY: 0001364742 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211] ORGANIZATION NAME: 02 Finance IRS NUMBER: 320174431 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-810-5300 MAIL ADDRESS: STREET 1: 50 HUDSON YARDS CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: BlackRock, Inc. DATE OF NAME CHANGE: 20060929 FORMER COMPANY: FORMER CONFORMED NAME: New BlackRock, Inc. DATE OF NAME CHANGE: 20060601 SC 13G 1 us28414h1032_012924.txt us28414h1032_012924.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) Elanco Animal Health Incorporated -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) 28414H103 -------------------------------------------------------- (CUSIP Number) December 31, 2023 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 28414H103 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 26146986 (6) Shared voting power 0 (7) Sole dispositive power 27781483 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 27781483 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 5.6% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- Elanco Animal Health Incorporated Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- 2500 INNOVATION WAY GREENFIELD IN 46140 Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ---------------------------------------

View on Read The Filing